An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- 8 Reasons Your Social Security Disability Claim Was Rejected
- 3 Tiny Stocks to Buy If Biotech Tumbles
- 5 Drugs That Investors May Be Undervaluing
- The Drug Development Process Explained in Detail and How It Impacts Your Investments
- The Reason Behind Sarepta Therapeutics Inc.'s Sinking Stock Price
- Is it Time for this Biotech to Change Management?